NASDAQ:TRIB Trinity Biotech Q1 2026 Earnings Report $0.36 +0.01 (+3.44%) Closing price 06/26/2026 04:00 PM EasternExtended Trading$0.34 -0.03 (-6.93%) As of 06/26/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Trinity Biotech EPS ResultsActual EPS-$0.23Consensus EPS -$0.31Beat/MissBeat by +$0.08One Year Ago EPSN/ATrinity Biotech Revenue ResultsActual Revenue$10.85 millionExpected Revenue$10.68 millionBeat/MissBeat by +$168.00 thousandYoY Revenue GrowthN/ATrinity Biotech Announcement DetailsQuarterQ1 2026Date6/16/2026TimeBefore Market OpensConference Call DateThursday, June 18, 2026Conference Call Time4:00PM ETUpcoming EarningsTrinity Biotech's Q2 2026 earnings is estimated for Thursday, September 3, 2026, based on past reporting schedulesConference Call ResourcesPress Release (6-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(6-K) Trinity Biotech Earnings HeadlinesTrinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling MarketJune 23, 2026 | globenewswire.comTrinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial ResultsJune 16, 2026 | globenewswire.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.June 27 at 1:00 AM | Porter & Company (Ad)Head to Head Survey: Trinity Biotech (NASDAQ:TRIB) & Innovative Eyewear (NASDAQ:LUCY)June 16, 2026 | americanbankingnews.comTrinity Biotech Launches New $4.35 Million ATM Program with Lucid, Ends Craig-Hallum MandateJune 12, 2026 | tipranks.comTrinity Biotech Plc Sponsored ADR Class AMay 23, 2026 | edition.cnn.comSee More Trinity Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Trinity Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trinity Biotech and other key companies, straight to your email. Email Address About Trinity BiotechTrinity Biotech (NASDAQ:TRIB) is a global diagnostic healthcare company headquartered in Bray, Ireland. The firm specializes in the development, manufacture and marketing of in vitro diagnostic products aimed at the detection and management of chronic and infectious diseases. Its offerings are designed to deliver timely and accurate results for a range of healthcare settings, from central laboratories to point‐of‐care environments. The company’s product portfolio includes a comprehensive array of assays and instrumentation. In the diabetes segment, Trinity Biotech provides hemoglobin A1c analyzers and glucose monitoring systems. It also offers serological and rapid tests for celiac disease, immunoassays for infectious diseases such as HIV and hepatitis B and C, and assays targeting cardiovascular risk markers. These products are used by hospitals, reference labs and clinics to support diagnosis, treatment monitoring and epidemiological surveillance. Trinity Biotech serves a worldwide customer base through direct sales operations in North America and Europe, together with a network of distributors in Asia Pacific, Latin America and the Middle East. Its manufacturing sites operate under internationally recognized quality standards, ensuring regulatory compliance across multiple jurisdictions. The company’s global footprint and supply chain infrastructure enable it to respond to regional healthcare needs efficiently. Supported by an experienced leadership team, Trinity Biotech maintains collaborations with research institutions and healthcare providers to drive innovation in diagnostic testing. Ongoing investment in product development and strategic partnerships underpins the company’s commitment to addressing emerging healthcare challenges and improving patient outcomes around the world.View Trinity Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings AloneFabrinet Is Becoming a Quiet Winner in the AI Optics BuildoutMicron’s HBM Surge Could Redefine the AI Growth StoryCarnival's Second Quarter: Is the Stock Still Complicated?Xcel Energy Stock Offers Stability as Electricity Demand BuildsThis Single Factor Is Holding Back Carvana’s Disruptive EdgePaychex Stock Looks Beaten Down, But Not Broken Upcoming Earnings NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)ASML (7/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
